{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T15:06:16Z","timestamp":1777734376406,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T00:00:00Z","timestamp":1660262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T00:00:00Z","timestamp":1660262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Pediatr"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s12519-022-00593-7","type":"journal-article","created":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T17:03:28Z","timestamp":1660323808000},"page":"771-777","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Neutropenia: diagnosis and management"],"prefix":"10.1007","volume":"18","author":[{"given":"Jing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7233-0354","authenticated-orcid":false,"given":"Run-Ming","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,12]]},"reference":[{"key":"593_CR1","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1053\/shem.2002.31919","volume":"39","author":"JEW Palmblad","year":"2002","unstructured":"Palmblad JEW, von Dem Borne AEGK. Idiopathic, immune, infectious, and idiosyncratic neutropenias. Semin Hematol. 2002;39:113.","journal-title":"Semin Hematol"},{"key":"593_CR2","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/j.1365-2141.2012.09171.x","volume":"158","author":"G Carlsson","year":"2012","unstructured":"Carlsson G, Fasth A, Bergl\u00f6f E, Lagerstedt-Robinson K, Nordenskj\u00f6ld M, Palmblad J, et al. Incidence of severe congenital neutropenia in Sweden and risk of evolution to myelodysplastic syndrome\/leukaemia. Brit J Haematol. 2012;158:363\u20139.","journal-title":"Brit J Haematol"},{"key":"593_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1034\/j.1600-0609.2001.00473.x","volume":"67","author":"HA Papadaki","year":"2001","unstructured":"Papadaki HA, Palmblad J, Eliopoulos GD. Non-immune chronic idiopathic neutropenia of adult: an overview. Eur J Haematol. 2001;67:35\u201344.","journal-title":"Eur J Haematol"},{"key":"593_CR4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1182\/asheducation-2016.1.38","volume":"2016","author":"PE Newburger","year":"2016","unstructured":"Newburger PE. Autoimmune and other acquired neutropenias. Hematology. 2016;2016:38\u201342.","journal-title":"Hematology"},{"key":"593_CR5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/stem.140151","volume":"14","author":"KE Brown","year":"1996","unstructured":"Brown KE, Young NS. Parvoviruses and bone marrow failure. Stem Cells (Dayton, Ohio). 1996;14:151\u201363.","journal-title":"Stem Cells (Dayton, Ohio)"},{"key":"593_CR6","first-page":"131","volume":"34","author":"V Bhatt","year":"2004","unstructured":"Bhatt V, Saleem A. Review: drug-induced neutropenia\u2013pathophysiology, clinical features, and management. Ann Clin Lab Sci. 2004;34:131.","journal-title":"Ann Clin Lab Sci"},{"key":"593_CR7","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1517\/17425255.2015.985649","volume":"11","author":"A Johnston","year":"2015","unstructured":"Johnston A, Uetrecht J. Current understanding of the mechanisms of idiosyncratic drug-induced agranulocytosis. Expert Opin Drug Met. 2015;11:243\u201357.","journal-title":"Expert Opin Drug Met"},{"key":"593_CR8","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/ajh.25483","volume":"94","author":"AH Ameri","year":"2019","unstructured":"Ameri AH, Curtis BR, Sykes DB. Immune neutropenia mediated by micafungin. Am J Hematol. 2019;94:830\u20132.","journal-title":"Am J Hematol"},{"key":"593_CR9","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1517\/14740338.7.4.481","volume":"7","author":"E Andr\u00e8s","year":"2008","unstructured":"Andr\u00e8s E, Federici L, Weitten T, Vogel T, Alt M. Recognition and management of drug-induced blood cytopenias: the example of drug-induced acute neutropenia and agranulocytosis. Expert Opin Drug Saf. 2008;7:481\u20139.","journal-title":"Expert Opin Drug Saf"},{"key":"593_CR10","doi-asserted-by":"publisher","first-page":"657","DOI":"10.7326\/0003-4819-146-9-200705010-00009","volume":"146","author":"F Andersohn","year":"2007","unstructured":"Andersohn F, Konzen C, Garbe E. Systematic review: agranulocytosis induced by nonchemotherapy drugs. Ann Intern Med. 2007;146:657\u201365.","journal-title":"Ann Intern Med"},{"key":"593_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2019.06.003","volume":"37","author":"SA Atallah-Yunes","year":"2019","unstructured":"Atallah-Yunes SA, Ready A, Newburger PE. Benign ethnic neutropenia. Blood Rev. 2019;37:100586.","journal-title":"Blood Rev"},{"key":"593_CR12","doi-asserted-by":"publisher","first-page":"E163","DOI":"10.1002\/ajh.25813","volume":"95","author":"I Fragiadaki","year":"2020","unstructured":"Fragiadaki I, Papadakis S, Sevastaki G, Sfyridaki K, Mavroudi I, Goulielmos GN, et al. Increased frequency of the single nucleotide polymorphism of the DARC\/ACKR1 gene associated with ethnic neutropenia in a cohort of European patients with chronic idiopathic neutropenia. Am J Hematol. 2020;95:E163\u20136.","journal-title":"Am J Hematol"},{"key":"593_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002108","volume":"7","author":"AP Reiner","year":"2011","unstructured":"Reiner AP, Lettre G, Nalls MA, Ganesh SK, Mathias R, Austin MA, et al. Genome-wide association study of white blood cell count in 16,388 African Americans: the continental origins and genetic epidemiology network (COGENT). PloS Genet. 2011;7:e1002108.","journal-title":"Plos Genet"},{"key":"593_CR14","first-page":"2800","volume":"10","author":"G Calabretto","year":"2021","unstructured":"Calabretto G, Teramo A, Baril\u00e0 G, Vicenzetto C, Gasparini VR, Semenzato G, et al. Neutropenia and large granular lymphocyte leukemia: from pathogenesis to therapeutic options. Cells (Basel, Switzerland). 2021;10:2800.","journal-title":"Cells (Basel, Switzerland)"},{"key":"593_CR15","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1189\/jlb.0607437","volume":"84","author":"J Karlsson","year":"2008","unstructured":"Karlsson J, Carlsson G, Larne O, Andersson M, P\u00fctsep K. Vitamin D3 induces pro-LL-37 expression in myeloid precursors from patients with severe congenital neutropenia. J Leukocyte Biol. 2008;84:1279\u201386.","journal-title":"J Leukocyte Biol"},{"key":"593_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MOH.0b013e3282f13cd2","volume":"15","author":"J Xia","year":"2008","unstructured":"Xia J, Link DC. Severe congenital neutropenia and the unfolded protein response. Curr Opin Hematol. 2008;15:1\u20137.","journal-title":"Curr Opin Hematol"},{"key":"593_CR17","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1182\/blood-2010-10-311704","volume":"117","author":"S Nanua","year":"2011","unstructured":"Nanua S, Murakami M, Xia J, Grenda DS, Woloszynek J, Strand M, et al. Activation of the unfolded protein response is associated with impaired granulopoiesis in transgenic mice expressing mutant Elane. Blood. 2011;117:3539\u201347.","journal-title":"Blood"},{"key":"593_CR18","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1182\/asheducation-2017.1.172","volume":"2017","author":"SJ Corey","year":"2017","unstructured":"Corey SJ, Oyarbide U. New monogenic disorders identify more pathways to neutropenia: from the clinic to next-generation sequencing. Hematol Am Soc Hematol Educ Program. 2017;2017:172\u201380.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"593_CR19","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.critrevonc.2018.10.003","volume":"133","author":"J Spoor","year":"2019","unstructured":"Spoor J, Farajifard H, Rezaei N. Congenital neutropenia and primary immunodeficiency diseases. Crit Rev Oncol Hematol. 2019;133:149\u201362.","journal-title":"Crit Rev Oncol Hematol"},{"key":"593_CR20","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/bjh.13823","volume":"172","author":"R Nustede","year":"2016","unstructured":"Nustede R, Klimiankou M, Klimenkova O, Kuznetsova I, Zeidler C, Welte K, et al. ELANE mutant-specific activation of different UPR pathways in congenital neutropenia. Br J Haematol. 2016;172:219\u201327.","journal-title":"Br J Haematol"},{"key":"593_CR21","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1182\/blood.V114.22.3206.3206","volume":"114","author":"PS Rosenberg","year":"2009","unstructured":"Rosenberg PS, Zeidler C, Bolyard AA, Alter BP, Bonilla MA, Dror Y, et al. Stable long-term risk of leukemia in patients with severe congenital neutropenia maintained on G-CSF therapy. Blood. 2009;114:3206.","journal-title":"Blood"},{"key":"593_CR22","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/sj.leu.2403663","volume":"19","author":"M Germeshausen","year":"2005","unstructured":"Germeshausen M, Schulze H, Kratz C, Wilkens L, Repp R, Shannon K, et al. An acquired G-CSF receptor mutation results in increased proliferation of CMML cells from a patient with severe congenital neutropenia. Leukemia. 2005;19:611\u20137.","journal-title":"Leukemia"},{"key":"593_CR23","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1182\/blood.V97.3.829","volume":"97","author":"M Germeshausen","year":"2001","unstructured":"Germeshausen M, Ballmaier M, Schulze H, Welte K, Flohr T, Beiske K, et al. Granulocyte colony-stimulating factor receptor mutations in a patient with acute lymphoblastic leukemia secondary to severe congenital neutropenia. Blood. 2001;97:829\u201330.","journal-title":"Blood"},{"key":"593_CR24","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.leukres.2014.03.020","volume":"38","author":"S Aref","year":"2014","unstructured":"Aref S, El-Ghonemy M, Abouzeid T, El-Sabbagh A, El-Baiomy M. Prevalence and impact of colony stimulating factor 3 receptor (CSF3R) mutations among Egyptian acute myeloid leukemia patients. Leukemia Res. 2014;38:722\u20135.","journal-title":"Leukemia Res"},{"key":"593_CR25","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1182\/blood-2013-11-538025","volume":"123","author":"J Skokowa","year":"2014","unstructured":"Skokowa J, Steinemann D, Katsman-Kuipers JE, Zeidler C, Klimenkova O, Klimiankou M, et al. Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis. Blood. 2014;123:2229\u201337.","journal-title":"Blood"},{"key":"593_CR26","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1038\/s41409-020-0800-1","volume":"55","author":"GA Rotulo","year":"2020","unstructured":"Rotulo GA, Beaupain B, Rialland F, Paillard C, Nachit O, Galambrun C, et al. HSCT may lower leukemia risk in ELANE neutropenia: a before-after study from the French Severe Congenital Neutropenia Registry. Bone Marrow Transplant. 2020;55:1614\u201322.","journal-title":"Bone Marrow Transplant"},{"key":"593_CR27","doi-asserted-by":"publisher","first-page":"17032","DOI":"10.1038\/nrdp.2017.32","volume":"3","author":"J Skokowa","year":"2017","unstructured":"Skokowa J, Dale DC, Touw IP, Zeidler C, Welte K. Severe congenital neutropenias. Nat Rev Dis Primers. 2017;3:17032.","journal-title":"Nat Rev Dis Primers"},{"key":"593_CR28","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/ijlh.13210","volume":"42","author":"JL Frater","year":"2020","unstructured":"Frater JL. How I investigate neutropenia. Int J Lab Hematol. 2020;42:121\u201332.","journal-title":"Int J Lab Hematol"},{"key":"593_CR29","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/bjh.14677","volume":"178","author":"DC Dale","year":"2017","unstructured":"Dale DC. How I manage children with neutropenia. Br J Haematol. 2017;178:351\u201363.","journal-title":"Br J Haematol"},{"key":"593_CR30","doi-asserted-by":"publisher","first-page":"e1259","DOI":"10.1542\/peds.2015-1638","volume":"136","author":"RD Christensen","year":"2015","unstructured":"Christensen RD, Yoder BA, Baer VL, Snow GL, Butler A. Early-onset neutropenia in small-for-gestational-age infants. Pediatrics. 2015;136:e1259\u201367.","journal-title":"Pediatrics"},{"key":"593_CR31","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1373\/clinchem.2013.202705","volume":"60","author":"H Delacour","year":"2014","unstructured":"Delacour H, Mornand P, Larr\u00e9ch\u00e9 S, Pilo JE, M\u00e9rens A, Imbert P. A neonatal agranulocytosis. Clin Chem. 2014;60:719\u201322.","journal-title":"Clin Chem"},{"key":"593_CR32","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/j.0958-7578.2005.00565.x","volume":"15","author":"YL Fung","year":"2005","unstructured":"Fung YL, Pitcher LA, Taylor K, Minchinton RM. Managing passively acquired autoimmune neonatal neutropenia: a case study. Transfus Med. 2005;15:151\u20135.","journal-title":"Transfus Med"},{"key":"593_CR33","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.3324\/haematol.2013.099101","volume":"99","author":"C Zeidler","year":"2014","unstructured":"Zeidler C, Grote UAH, Nickel A, Brand B, Carlsson G, Cortes\u00e3o E, et al. Outcome and management of pregnancies in severe chronic neutropenia patients by the European Branch of the Severe Chronic Neutropenia International Registry. Haematologica (Roma). 2014;99:1395\u2013402.","journal-title":"Haematologica (Roma)"},{"key":"593_CR34","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1182\/blood.V91.1.181","volume":"91","author":"J Bux","year":"1998","unstructured":"Bux J, Behrens G, Jaeger G, Welte K. Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases. Blood. 1998;91:181\u20136.","journal-title":"Blood"},{"key":"593_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26904","volume":"65","author":"L Porretti","year":"2018","unstructured":"Porretti L, Farruggia P, Colombo FS, Cattaneo A, Ghilardi R, Mirra N, et al. Diagnostic value of cell bound and circulating neutrophil antibody detection in pediatric neutropenia. Pediatr Blood Cancer. 2018;65:e26904.","journal-title":"Pediatr Blood Cancer"},{"key":"593_CR36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1177\/2040620714556642","volume":"6","author":"P Farruggia","year":"2015","unstructured":"Farruggia P, Dufour C. Diagnosis and management of primary autoimmune neutropenia in children: insights for clinicians. Ther Adv Hematol. 2015;6:15\u201324.","journal-title":"Ther Adv Hematol"},{"key":"593_CR37","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3892\/etm.2021.9711","volume":"21","author":"C Jinca","year":"2021","unstructured":"Jinca C, Serban M, Ursu E, Munteanu A, Arghirescu S. Primary autoimmune neutropenia of infancy and childhood in a cohort of patients from western Romania. Exp Ther Med. 2021;21:280.","journal-title":"Exp Ther Med"},{"key":"593_CR38","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1056\/NEJMc1709258","volume":"377","author":"DC Dale","year":"2017","unstructured":"Dale DC, Bolyard A, Marrero T, Makaryan V, Bonilla M, Link DC, et al. Long-term effects of G-CSF therapy in cyclic neutropenia. N Engl J Med. 2017;377:2290\u20132.","journal-title":"N Engl J Med"}],"container-title":["World Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-022-00593-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12519-022-00593-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-022-00593-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T17:32:27Z","timestamp":1700933547000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12519-022-00593-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,12]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["593"],"URL":"https:\/\/doi.org\/10.1007\/s12519-022-00593-7","relation":{},"ISSN":["1708-8569","1867-0687"],"issn-type":[{"value":"1708-8569","type":"print"},{"value":"1867-0687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,12]]},"assertion":[{"value":"3 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not needed for a commentary.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Author Run-Ming Jin is the editorial board member of World Journal of Pediatrics. The paper was handled by the other Editor and has undergone rigrous peer review process. Author Run-Ming Jin was not involved in the journal's review of, or decisions related to, this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}